Mannitol inhalation powder
What is this medicine?
MANNITOL (MAN i tawl) is a bronchoconstrictor. It is used for a breathing test. The test helps your doctor understand how your lungs work.
How should I use this medicine?
This medicine is for inhalation through the mouth. It is given by a health care professional in a hospital or clinic setting.
Talk to your pediatrician regarding the use of this medicine in children. While this drug may be prescribed for children as young as 6 years of age for selected conditions, precautions do apply.
What side effects may I notice from receiving this medicine?
Side effects that you should report to your doctor or health care professional as soon as possible:
Side effects that usually do not require medical attention (report to your doctor or health care professional if they continue or are bothersome):
chest pain or chest tightness
What may interact with this medicine?
Interactions are not expected. However, check with your doctor if you take any medicines regularly, and ask when you are allowed to take them prior to and after the test.
What if I miss a dose?
This does not apply.
Where should I keep my medicine?
This drug is given in a hospital or clinic and will not be stored at home.
What should I tell my health care provider before I take this medicine?
They need to know if you have any of these conditions:
aortic or brain aneurysm
coughing up blood
high blood pressure
history of stroke
lung or breathing disease, like asthma
an unusual or allergic reaction to mannitol, gelatin, other medicines, foods, dyes, or preservatives
pregnant or trying to get pregnant
What should I watch for while using this medicine?
You will be monitored carefully while you are receiving this medicine during your test.
During the testing you may feel a little bit breathless. The tests can also make you cough and lightheaded for a few seconds. This is normal. If you feel very breathless, let the health care professional performing the test know. You will also be monitored for a short time after testing, after which you will be expected to resume normal activities.
July 10, 2017